1. Home
  2. NNBR vs ELTX Comparison

NNBR vs ELTX Comparison

Compare NNBR & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNBR
  • ELTX
  • Stock Information
  • Founded
  • NNBR 1980
  • ELTX 2011
  • Country
  • NNBR United States
  • ELTX United States
  • Employees
  • NNBR N/A
  • ELTX N/A
  • Industry
  • NNBR Industrial Machinery/Components
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNBR Industrials
  • ELTX Health Care
  • Exchange
  • NNBR Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • NNBR 149.8M
  • ELTX 121.7M
  • IPO Year
  • NNBR 1994
  • ELTX N/A
  • Fundamental
  • Price
  • NNBR $1.70
  • ELTX $4.76
  • Analyst Decision
  • NNBR
  • ELTX Strong Buy
  • Analyst Count
  • NNBR 0
  • ELTX 2
  • Target Price
  • NNBR N/A
  • ELTX $9.50
  • AVG Volume (30 Days)
  • NNBR 177.5K
  • ELTX 45.3K
  • Earning Date
  • NNBR 05-05-2025
  • ELTX 05-14-2025
  • Dividend Yield
  • NNBR N/A
  • ELTX N/A
  • EPS Growth
  • NNBR N/A
  • ELTX N/A
  • EPS
  • NNBR N/A
  • ELTX N/A
  • Revenue
  • NNBR $464,290,000.00
  • ELTX N/A
  • Revenue This Year
  • NNBR $0.82
  • ELTX N/A
  • Revenue Next Year
  • NNBR $6.29
  • ELTX N/A
  • P/E Ratio
  • NNBR N/A
  • ELTX N/A
  • Revenue Growth
  • NNBR N/A
  • ELTX N/A
  • 52 Week Low
  • NNBR $1.69
  • ELTX $3.34
  • 52 Week High
  • NNBR $4.67
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • NNBR 27.23
  • ELTX 30.36
  • Support Level
  • NNBR $1.58
  • ELTX $4.61
  • Resistance Level
  • NNBR $2.00
  • ELTX $5.11
  • Average True Range (ATR)
  • NNBR 0.21
  • ELTX 0.69
  • MACD
  • NNBR -0.03
  • ELTX -0.07
  • Stochastic Oscillator
  • NNBR 13.64
  • ELTX 5.56

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: